[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@MatteMuscat Matteo MuscatMatteo Muscat posts on X about return on investment, investment, return on, insurance the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance
Social topic influence return on investment, investment, return on, insurance, $20m, cash flow, $15m, debt, $2025m, $6m10m
Top assets mentioned Hundred Million (100M)
Top posts by engagements in the last XX hours
"Most U.S. RCMs grow through sales and marketing. They spend about XXX% of revenue to get X% more revenue each year. If the company runs at XX% profit margins thats a XX% return on investment. It works. But it requires big expensive U.S. sales teams. Because selling to large hospitals takes a long time. CareCloud grows differently. It buys and fixes struggling RCMs. The business model is strong because they keep: - Low fixed costs. $6M in working cash and $5M in equipment - Low operational costs. Their Pakistan team costs XX% lower than U.S teams - Fast cash flow. They control the health"
X Link @MatteMuscat 2025-10-26T16:00Z 1347 followers, XXX engagements
"CareCloud does Revenue Cycle Management (RCM). They make sure U.S. healthcare providers get paid for the care they deliver. The process works like this: X. Before the visit. Check the patients insurance X. During the visit. Turn the doctors notes into billing codes X. After the visit. Send those codes as claims to insurers. If insurers reject a claim CareCloud corrects it and sends it again. Then it bills the patient for whats left. And collects the payment. RCM runs on software like: - Electronic Health Records (EHR) to store information and - Practice Management (PM) to handle admin tasks."
X Link @MatteMuscat 2025-10-25T15:00Z 1345 followers, XXX engagements
"By the end of 2025 CareCloud will have $20M in cash. That alone could buy $15M in revenue. With debt and seller financing they could do a $20-25M deal. Adding $6M-10M in EBITDA. This would lift total 2026 EBITDA to $33M-37M. If they repeat the play the year after EBITDA could reach $39-47M. That translates to $20-27M in free cash flow. Vs todays $100M market cap. The stock is cheap now. And even cheaper looking forward. @bilbelcapital Capital 2025 Semi Annual Letter $CCLD"
X Link @MatteMuscat 2025-11-02T16:00Z 1346 followers, XXX engagements